$COCP 8-K SEC Filings

Filed On	Filing
09 Sep 2026	8-K: Regulation FD Disclosure Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
18 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Aug 2026	8-K: Regulation FD Disclosure
03 Aug 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
17 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders
09 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
03 Jun 2026	8-K: Regulation FD Disclosure
26 May 2026	8-K: Regulation FD Disclosure
30 Apr 2026	8-K: Regulation FD Disclosure
02 Apr 2026	8-K: Regulation FD Disclosure
31 Mar 2026	8-K: Results of Operations and Financial Condition
13 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
09 Mar 2026	8-K: Regulation FD Disclosure
19 Feb 2026	8-K: Regulation FD Disclosure
15 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
18 Dec 2025	8-K: Regulation FD Disclosure
01 Dec 2025	8-K: Regulation FD Disclosure
14 Nov 2025	8-K: Results of Operations and Financial Condition
30 Oct 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
27 Oct 2025	8-K: Regulation FD Disclosure

Comments